David Murdock: Identifying High-Risk Variants of Uncertain Significance in Aortopathy Genes
David Murdock, Assistant Professor at The University of Texas Health Science Center at Houston, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Genetics in Medicine, adding:
“Excited to share our recent publication in Genetics in Medicine on identifying high-risk variants of uncertain significance (VUS) in aortopathy genes.
Using bioinformatic tools, we show how select VUS are strongly associated with increased risk of aortic dissection, helping move genetic findings closer to clinical action.”
Title: Using bioinformatic tools to identify high-risk variants of uncertain significance in aortopathy genes that increase aortic dissection risk
Authors: John DePaolo, Dong-chuan Guo, David R. Murdock, Alana C. Cecchi, Scott A. LeMaire, Hu Ying Shen, Anthony L. Estrera, Hazim J. Safi, Joseph S. Coselli, Josh Smith, Michael J. Bamshad, Scott Damrauer, Dianna M. Milewicz

Stay updated on all scientific advances with Hemostasis Today.
-
Aug 31, 2026, 14:32Mahir Khalil Ibrahim Jallo: Hot Topic From The ESC 2026 Munich
-
Aug 31, 2026, 14:28Ruben Mesa: FDA Approves Ropeginterferon Alfa-2b for Essential Thrombocythemia
-
Aug 31, 2026, 14:28Francisco Chacón-Lozsán: Should We Anticoagulate AF Patients With Only One Non-Sex Stroke Risk Factor?
-
Aug 31, 2026, 14:24Akl Fahed: Do Lifelong Differences in LDL Cholesterol Influence the Risk of Venous Thromboembolism?
-
Aug 31, 2026, 14:23Accelerating CAR-T Access Through Policy and System Reform – American Society of Hematology
-
Aug 31, 2026, 14:21Shirya Rashid: Does Bempedoic Acid Influence Venous Thromboembolism Risk?
-
Aug 31, 2026, 14:14Jason Andrade: SINGLE-AF Trial Validates Early Anticoagulation in AF
-
Aug 31, 2026, 14:12Leonardo Roever: Diagnosis and Management of Natural Anticoagulant Deficiencies
-
Aug 31, 2026, 14:07Ben Dowsing: Can Heart Failure Therapy Be Safely Withdrawn After HER2 Cardiotoxicity Recovery